RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0034-1376260
Vascular Tumors
Authors
Publikationsverlauf
Publikationsdatum:
31. Mai 2014 (online)
Abstract
Vascular anomalies are divided into two main groups: tumors and malformations. Vascular tumors are a large and complex group of lesions, especially for clinicians with none or little experience in this field. In the past, these lesions caused a great deal of confusion because many appear analogous to the naked eye. Thankfully, recent advances in diagnostic techniques have helped the medical community to enhance our comprehension, accurately label, diagnose, and treat these lesions. In this article, we will review the most frequent vascular tumors and provide the reader with the tools to properly label, diagnose, and manage these complex lesions.
-
References
- 1 Hassanein AH, Mulliken JB, Fishman SJ, Greene AK. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg 2011; 127 (1) 347-351
- 2 Burns AJ, Navarro JA, Cooner RD. Classification of vascular anomalies and the comprehensive treatment of hemangiomas. Plast Reconstr Surg 2009; 124 (1, Suppl) 69e-81e
- 3 Gampper TJ, Morgan RF. Vascular anomalies: hemangiomas. Plast Reconstr Surg 2002; 110 (2) 572-585 , quiz 586, discussion 587–588
- 4 Lowe LH, Marchant TC, Rivard DC, Scherbel AJ. Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol 2012; 47 (2) 106-117
- 5 Arneja JS, Pappas PN, Shwayder TA , et al. Management of complicated facial hemangiomas with beta-blocker (propranolol) therapy. Plast Reconstr Surg 2010; 126 (3) 889-895
- 6 North PE. Pediatric vascular tumors and malformations. Surg Pathol 2010; 3: 455-494
- 7 Maguiness SM, Frieden IJ . Vascular Birthmarks. In: L.A. Schachner & R. C. Hansen, eds. Pediatric Dermatology. 4 th ed. Philadelphia, PA: Mosby; 2011
- 8 Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg 2005; 32 (1) 99-116 , ix
- 9 Picard A, Boscolo E, Khan ZA , et al. IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res 2008; 63 (3) 263-267
- 10 Barnés CM, Huang S, Kaipainen A , et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A 2005; 102 (52) 19097-19102
- 11 Richter GT, Friedman AB. Hemangiomas and vascular malformations: current theory and management. Int J Pediatr 2012; 2012: 645678
- 12 Maguiness SM, Frieden IJ. Current management of infantile hemangiomas. Semin Cutan Med Surg 2010; 29 (2) 106-114
- 13 Chim H, Drolet B, Duffy K, Koshima I, Gosain AK. Vascular anomalies and lymphedema. Plast Reconstr Surg 2010; 126 (2) 55e-69e
- 14 Donnelly LF, Adams DM, Bisset III GS. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol 2000; 174 (3) 597-608
- 15 Metry D, Heyer G, Hess C , et al; PHACE Syndrome Research Conference. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009; 124 (5) 1447-1456
- 16 Coldwell DM, Baron RL, Charnsangavej C. Angiosarcoma. Diagnosis and clinical course. Acta Radiol 1989; 30 (6) 627-631
- 17 Fata F, O'Reilly E, Ilson D , et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999; 86 (10) 2034-2037
- 18 Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol 2010; 11 (10) 983-991